Pharmacovigilance Analysis of Cardiac Toxicities Associated With Targeted Therapies for Metastatic NSCLC-Reference-Cited by-同舟云学术

Pharmacovigilance Analysis of Cardiac Toxicities Associated With Targeted Therapies for Metastatic NSCLC

Published:2021-12 Issue:12 Volume:16 Page:2029-2039
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Waliany Sarah,Zhu Han,Wakelee Heather,Padda Sukhmani K.,Das Millie,Ramchandran Kavitha,Myall Nathaniel J.,Chen Thomas,Witteles Ronald M.,Neal Joel W.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference38 articles.

1. Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy;Skoulidis;Nat Rev Cancer,2019

2. The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis;Zhang;Oncotarget,2016

3. Overview of clinicopathologic features of ALK-rearranged lung adenocarcinoma and current diagnostic testing for ALK rearrangement;Kim;Transl Lung Cancer Res,2015

4. ROS1 rearrangements define a unique molecular class of lung cancers;Bergethon;J Clin Oncol,2012

5. Clinical features and outcome of patients with non-small-cell lung cancer harboring BRAF mutations;Marchetti;J Clin Oncol,2011

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer and Heart Failure: Dangerous Liaisons;Journal of Cardiovascular Development and Disease;2024-08-27

2. Advancements in understanding cardiotoxicity of EGFR- TKIs in non-small cell lung cancer treatment and beyond;Frontiers in Pharmacology;2024-08-15

3. Real‐world evidence of brigatinib as second‐line treatment after crizotinib for ALK+ non‐small cell lung cancer using South Korean claims data (K‐AREAL);Cancer Medicine;2024-07

4. Osimertinib-Related QTc Prolongation: Real-World Incidence and Impact of Drug Dosing on Recurrence Risk;Clinical Lung Cancer;2024-07

5. Heart Failure With Reduced Ejection Fraction in a Patient With Erdheim-Chester Disease on Dabrafenib;JACC: Case Reports;2024-06